Cisplatin from Tocris Bioscience, a Bio-Techne Brand | Biocompare.com

Supplier Images

Cisplatin

Potent pro-apoptotic anticancer agent; activates caspase-3

Be the first to write a review!

Citations:

Supplier Page from
Tocris Bioscience, a Bio-Techne Brand for
Cisplatin

Description

Potent pro-apoptotic anticancer agent; activates caspase-3

Product Specs
ItemCisplatin
CompanyTocris Bioscience, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog Number2251/50
Quantity50 mg
Brand/TrademarkTocris, a Bio-Techne Brand
Molecular Weight300.05
Molecule Namecis-Diaminodichloroplatinum
FormulaCl₂H₆N₂Pt
StorageStore at RT

Add to Compare List

Tocris Bioscience, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956
Fax: 1 (612) 656-4400

Company Profile

Website: http://www.tocris.com

(1) TIMP-1-Mediated Chemoresistance via Induction of IL-6 in NSCLCCancersAugust 15, 2019Xiao W, Wang L, Howard J, Kolhe R, Rojiani AM, Rojiani MV.

(2) Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistanceOncogeneMarch 1, 2019Su F, Ahn S, Saha A, DiGiovanni J, Kolonin MG.

(3) TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell CarcinomaCell stem cellNovember 2, 2017Brown JA, Yonekubo Y, Hanson N, Sastre-Perona A, Basin A, Rytlewski JA, Dolgalev I, Meehan S, Tsirigos A, Beronja S, et al.

(4) Phenotype-driven precision oncology as a guide for clinical decisions one patient at a timeNature communicationsSeptember 5, 2017Chia S, Low JL, Zhang X, Kwang XL, Chong FT, Sharma A, Bertrand D, Toh SY, Leong HS, Thangavelu MT, et al.

(5) The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and TumorsMolecular cancer therapeuticsJune 1, 2017Zhang H, Patel A, Wang YJ, Zhang YK, Kathawala RJ, Qiu LH, Patel BA, Huang LH, Shukla S, Yang DH, et al.

(6) Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastomaOncotargetApril 4, 2017Florea AM, Varghese E, McCallum JE, Mahgoub S, Helmy I, Varghese S, Gopinath N, Sass S, Theis FJ, Reifenberger G, et al.

(7) Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in CultureThe Journal of pharmacology and experimental therapeuticsJanuary 1, 2017Deng L, Ng L, Ozawa T, Stella N.

(8) Identification of therapeutic targets applicable to clinical strategies in ovarian cancerBMC cancerAugust 24, 2016Kim MK, Caplen N, Chakka S, Hernandez L, House C, Pongas G, Jordan E, Annunziata CM.

(9) Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian CancerPloS oneJanuary 1, 2016Fedoseienko A, Wieringa HW, Wisman GB, Duiker E, Reyners AK, Hofker MH, van der Zee AG, van de Sluis B, van Vugt MA.

(10) SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2Cell death & diseaseNovember 19, 2015Sun R, Jiang B, Qi H, Zhang X, Yang J, Duan J, Li Y, Li G.

(11) A New Rat Model of Cisplatin-induced Neuropathic PainThe Korean journal of painOctober 1, 2015Lin H, Heo BH, Yoon MH.

(12) Triglyceride-Rich Lipoproteins Modulate the Distribution and Extravasation of Ly6C/Gr1(low) MonocytesCell reportsSeptember 22, 2015Saja MF, Baudino L, Jackson WD, Cook HT, Malik TH, Fossati-Jimack L, Ruseva M, Pickering MC, Woollard KJ, Botto M.

(13) Tolerance to the antinociceptive effects of chronic morphine requires c-Jun N-terminal kinaseMolecular painJune 12, 2015Marcus DJ, Zee M, Hughes A, Yuill MB, Hohmann AG, Mackie K, Guindon J, Morgan DJ.

(14) Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic targetMolecular cancer therapeuticsJanuary 1, 2015Liu Y, Kwiatkowski DJ.

(15) The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic studyOncotargetJanuary 1, 2015Kathawala RJ, Wei L, Anreddy N, Chen K, Patel A, Alqahtani S, Zhang YK, Wang YJ, Sodani K, Kaddoumi A, et al.

(16) Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health statusMolecular painSeptember 4, 2014Guindon J, Deng L, Fan B, Wager-Miller J, Hohmann AG.

(17) Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistanceInternational journal of oncologyMay 1, 2014Kathawala RJ, Chen JJ, Zhang YK, Wang YJ, Patel A, Wang DS, Talele TT, Ashby CR Jr, Chen ZS.

(18) Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical studyMolecular cancer therapeuticsMarch 1, 2014Kathawala RJ, Sodani K, Chen K, Patel A, Abuznait AH, Anreddy N, Sun YL, Kaddoumi A, Ashby CR Jr, Chen ZS.

(19) The heterogenic final cell cycle of chicken retinal Lim1 horizontal cells is not regulated by the DNA damage response pathwayCell cycle (Georgetown, Tex.)January 1, 2014Shirazi Fard S, All-Ericsson C, Hallböök F.

(20) Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancerPloS oneJanuary 1, 2014Szabova L, Bupp S, Kamal M, Householder DB, Hernandez L, Schlomer JJ, Baran ML, Yi M, Stephens RM, Annunziata CM, et al.

Be the First to Write a Review!